Imdelltra, a bispecific antibody targeting a protein called DLL3, is cleared for use following chemotherapy in treating extensive-stage small cell lung cancer.

It says provinces and territories should work toward providing the antibody drug Nirsevimab for all infants before their ...

Telix already has a product on the market, a prostate cancer imaging agent called Illuccix. The company’s lead drug candidate, a radio antibody-drug conjugate called TLX591, is in Phase 3 testing for ...

Bolt Biotherapeutics shares fell 37% after shelving its lead candidate, pivoting its pipeline, halving its staff, and upending its C-suite.

The Phase Ia trial will evaluate the safety and efficacy of Voyager’s tau-targeting humanised IgG4 monoclonal antibody ...

“To get a broadly neutralizing antibody, a series of events needs to happen, and it typically takes several years post-infection,” says lead author Wilton Williams, Ph.D., an associate professor in ...

Studies in mice and monkeys showed that immune cells could be shepherded to produce antibodies that block a broad swath of ...

A trial vaccine has succeeded in generating low levels of antibodies needed to target HIV. It’s a first but much-needed step ...

An HIV vaccine candidate triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a small group of people enrolled in a 2019 clinical trial.

An HIV vaccine candidate developed at the Duke Human Vaccine Institute triggered low levels of an elusive type of broadly ...

Global Anti Neurofilament L Antibody Industry is to reach a valuation of US$ 145 Billion in 2022, likely to surge at a 11% ...

AstraZeneca said that a new long-acting antibody reduced immunocompromised patients’ risks of contracting symptomatic ...